Abstract
Conclusion
The incidence of deaths due to arteriosclerotic heart disease is being compared in men recovered from myocardial infarction and treated 75 days or more with either Premarin or no estrogen (control), allocation of treatments being randomized. Survival rate in those receiving Premarin is significantly higher than in controls.
Get full access to this article
View all access options for this article.